Please use this form to send email to PR contact of this press release:
Panacea Life Sciences, Inc Closes Series A Investment Round with 22nd Century Group to Expand CBD Operations

Nicholas J. Cavarra
Panacea Life Sciences, Inc.
+1 303-886-5538


Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image